Copyright
©The Author(s) 2018.
World J Gastroenterol. Mar 21, 2018; 24(11): 1196-1205
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1196
Published online Mar 21, 2018. doi: 10.3748/wjg.v24.i11.1196
Table 2 Numbers and maximum changes of up- and downregulated genes in peripheral blood mononuclear cells from Crohn’s disease patient vs identically treated controls
| Treatment of PBMCs | Upregulated genes | Downregulated genes |
| Untreated | 85 (59-fold) | 39 (39-fold) |
| Vitamin D3 | 25 (21-fold) | 12 (9-fold) |
| LPS/PGN | 54 (6-fold) | 15 (5-fold) |
| Vitamin D3 + LPS/PGN | 29 (15-fold) | 8 (5-fold) |
- Citation: Schäffler H, Rohde M, Rohde S, Huth A, Gittel N, Hollborn H, Koczan D, Glass Ä, Lamprecht G, Jaster R. NOD2- and disease-specific gene expression profiles of peripheral blood mononuclear cells from Crohn’s disease patients. World J Gastroenterol 2018; 24(11): 1196-1205
- URL: https://www.wjgnet.com/1007-9327/full/v24/i11/1196.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i11.1196